This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2003 Jul 24;349(4):366-81.

doi: 10.1056/NEJMra021562.

Prostate cancer

William G Nelson¹, Angelo M De Marzo, William B Isaacs

Affiliations

PMID: 12878745
DOI: 10.1056/NEJMra021562

Review

Prostate cancer

William G Nelson et al. N Engl J Med. 2003.

. 2003 Jul 24;349(4):366-81.

doi: 10.1056/NEJMra021562.

Authors

William G Nelson¹, Angelo M De Marzo, William B Isaacs

Affiliation

¹ Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, USA. bnelson@jhmi.edu

PMID: 12878745
DOI: 10.1056/NEJMra021562

No abstract available

PubMed Disclaimer

Similar articles

Prostate cancer: 3. Individual risk factors.
Gallagher RP, Fleshner N. Gallagher RP, et al. CMAJ. 1998 Oct 6;159(7):807-13. CMAJ. 1998. PMID: 9805030 Free PMC article. Review. No abstract available.
A germ line mutation that delays prostate cancer progression and prolongs survival in a murine prostate cancer model.
Majeed N, Blouin MJ, Kaplan-Lefko PJ, Barry-Shaw J, Greenberg NM, Gaudreau P, Bismar TA, Pollak M. Majeed N, et al. Oncogene. 2005 Jul 7;24(29):4736-40. doi: 10.1038/sj.onc.1208572. Oncogene. 2005. PMID: 15870705
Prostate cancer prevention: risk reduction through life-style, diet, and chemoprevention.
Greco KE, Kulawiak L. Greco KE, et al. Oncol Nurs Forum. 1994 Oct;21(9):1504-11. Oncol Nurs Forum. 1994. PMID: 7816677 Review.
BRCA1 and BRCA2 have a limited role in familial prostate cancer.
Sinclair CS, Berry R, Schaid D, Thibodeau SN, Couch FJ. Sinclair CS, et al. Cancer Res. 2000 Mar 1;60(5):1371-5. Cancer Res. 2000. PMID: 10728701
Molecular heterogeneity in prostate cancer: can TP53 mutation unravel tumorigenesis?
Roy-Burman P, Zheng J, Miller GJ. Roy-Burman P, et al. Mol Med Today. 1997 Nov;3(11):476-82. doi: 10.1016/S1357-4310(97)01126-X. Mol Med Today. 1997. PMID: 9430782

See all similar articles

Cited by

Improving the identification of high-risk non-metastatic castration-resistant prostate cancer patients in clinical practice.
Rosinha A, Rabaça C, Calais F, Pinto JM, Barreira JV, Fernandes R, Ramos R, Fialho AC, Palma Dos Reis J. Rosinha A, et al. Front Oncol. 2024 Jan 23;13:1266369. doi: 10.3389/fonc.2023.1266369. eCollection 2023. Front Oncol. 2024. PMID: 38322282 Free PMC article.
Computational Reconstruction of NFκB Pathway Interaction Mechanisms during Prostate Cancer.
Börnigen D, Tyekucheva S, Wang X, Rider JR, Lee GS, Mucci LA, Sweeney C, Huttenhower C. Börnigen D, et al. PLoS Comput Biol. 2016 Apr 14;12(4):e1004820. doi: 10.1371/journal.pcbi.1004820. eCollection 2016 Apr. PLoS Comput Biol. 2016. PMID: 27078000 Free PMC article.
Prostate cancer and inflammation: the evidence.
Sfanos KS, De Marzo AM. Sfanos KS, et al. Histopathology. 2012 Jan;60(1):199-215. doi: 10.1111/j.1365-2559.2011.04033.x. Histopathology. 2012. PMID: 22212087 Free PMC article. Review.
Modest induction of phase 2 enzyme activity in the F-344 rat prostate.
Jones SB, Brooks JD. Jones SB, et al. BMC Cancer. 2006 Mar 15;6:62. doi: 10.1186/1471-2407-6-62. BMC Cancer. 2006. PMID: 16539699 Free PMC article.
Search for Novel Diagnostic Biomarkers of Prostate Inflammation-Related Disorders: Role of Transglutaminase Isoforms as Potential Candidates.
Savoca MP, Inferrera A, Verderio EAM, Caccamo D. Savoca MP, et al. Mediators Inflamm. 2019 Jul 9;2019:7894017. doi: 10.1155/2019/7894017. eCollection 2019. Mediators Inflamm. 2019. PMID: 31360119 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information